hepatocellular 中文意思是什麼
hepatocellular
解釋
肝細胞的-
Hepatocellular adenoma a clinical study of 36 cases
肝細胞腺瘤36例臨床分析 -
Diagnosis and treatment of hepatocellular adenoma
肝細胞腺瘤的診斷和治療 -
Multislice spiral ct angiography applied in hepatocellular carcinoma
血管成像在肝細胞癌中的應用 -
P120ctn weakly expressed or disappeared at membrane in hepatocellular carcinoma tissues, immunoreaction were detected in cytosol and nucleus, it suggested that the molecule had translocated and cells lost adhesion abilities had malfunction in signaling, also p - catenin had similar changes as p120ctn
20林mol . l一,的芒果貳能幹擾bel一7404細胞周期,使細胞阻止於q一m ,同時有誘導細胞凋亡的作用,其作用於48小時時就很明顯。 -
Patients with cirrhosis have significantly shortened life spans and are at risk for decompensation and hepatic failure, as well as the development of hepatocellular carcinoma
肝硬化患者會明顯縮短壽命,並有肝失代償和肝衰竭的危險,並有發展成肝癌的可能。 -
Pathologic findings of the specimen got from the spinal erector muscle tumor confirmed the diagnosis of hepatocellular carcinoma
病人經其他多項檢查,皆未發現有其他部位之轉移。 -
The malignant cells of this hepatocellular carcinoma ( seen mostly on the right ) are well differentiated and interdigitate with normal, larger hepatocytes ( seen mostly at the left )
該肝細胞癌的惡性腫瘤細胞(主要位於右方)分化較好,並與較大的正常肝細胞(主要位於左方)相互交錯。 -
Role of the hepatocellular microsome cytochrome p450 of rats in regulation of body temperature
450在體溫調節中作用的探討 -
A study on vasculogenic mimicry in hepatocellular carcinoma
肝細胞肝癌中血管生成擬態的研究 -
Osteopontin promotes the malignant phenotypes of human hepatocellular carcinoma cell line smmc
7721惡性表型的實驗研究 -
Expression and significance of rel mrna and nf - b2 mrna in hepatocellular carcinoma
在人肝細胞癌中的表達及其臨床意義 -
Sclerosing ( or scirrhous ) hepatocellular carcinoma is a subtype of hepatocellular carcinoma
摘要硬化型肝癌是一少見之肝癌亞型。 -
Effect of tea polyphenal on chemopreventing hepatocellular carcinoma of tree shrew
茶多酚在樹?肝癌形成中的化學預防作用 -
Tace for hepatocellular carcinoma with involvement of the internal mammary artery
內乳動脈供血肝癌的介入治療 -
Transcatheter arterial chemoembolization ( tace ) offers a good alternative choice and improves the survival in the treatment of unresectable hepatocellular carcinoma
摘要經導管動脈化學栓塞療法對于不能切除的肝細胞癌是一個很好的治療方式,而且能改善存活率。 -
A 77 - year - old man, who had undergone tace and hepatic surgery for hepatocellular carcinoma twice, was admitted due to biliptysis and dyspnea
一位因肝癌而曾經接受過兩次局部肝切除手術和動脈導管化學栓塞的七十七歲男性病人,因為氣促以及咳嗽中帶有膽汁而住院接受治療。 -
Experimental study of transferrin receptor molecular imaging in human hepatocellular carcinoma transplanted in nude mice
裸鼠中人肝細胞癌轉鐵蛋白受體的分子顯像研究 -
The expression of survivin mrna and its clinical significance in hepatocellular carcinoma of high aflatoxin b1 risk area
1高暴露地區肝細胞癌中的表達及其臨床意義 -
Barcelona, spain - - september 28, 2007 - - sorafenib significantly prolongs survival in patients with advanced hepatocellular carcinoma compared with placebo, investigators reported here at the 14th european cancer conference ( ecco )
西班牙,巴塞羅那? ? 2007年9月28日。和安慰劑對比,索拉非尼明顯延長晚期肝癌病人生存時間。在第14屆歐洲癌癥會議( ecco )上,相關研究者報道說。 -
Diagnosis and treatment of - fetoprotein - negative small hepatocellular carcinoma
甲胎蛋白陰性小肝細胞癌的診斷與處理
分享友人